This is the most plausible explanation for why retatrutide's Phase 2 weight-loss readouts (up to 24.2% at 48 weeks) sit above comparable tirzepatide and semaglutide datasets [3][11]
The previous largest one-year drop was 4% in 2018, according to the agencys National Center for Health Statistics
Estrogen may play a role in low flow POTS by decreasing renin levels, decreasing ACE activity and thereby increasing BKN, decreasing AT1 receptor density and decreasing aldosterone (Ma et al., 2021)
The reason is that if it is injected into veins a portion of the shot may pass out of the body through urine
Why does CagriSema use two peptides instead of one molecule like tirzepatide
The tech-money biohacking crowd already pays for blood panels, hormone work, and longevity consults, so semaglutide and tirzepatide slot into routines that were built for self-experimentation